Tau phosphorylation, aggregation, and cell toxicity
- PMID: 17047313
- PMCID: PMC1479889
- DOI: 10.1155/JBB/2006/74539
Tau phosphorylation, aggregation, and cell toxicity
Abstract
Protein aggregation takes place in many neurodegenerative disorders. However, there is a controversy about the possible toxicity of these protein aggregates. In this review, this controversy is discussed, focussing on the tau aggregation that takes place in those disorders known as tauopathies.
References
-
- Prusiner SB. Shattuck lecture—neurodegenerative diseases and prions. The New England Journal of Medicine. 2001;344(20):1516–1526. - PubMed
-
- Sadqi M, Hernández F, Pan U, et al. Alpha-helix structure in Alzheimer's disease aggregates of tau-protein. Biochemistry. 2002;41(22):7150–7155. - PubMed
-
- Arrasate M, Mitra S, Schweitzer ES, Segal MR, Finkbeiner S. Inclusion body formation reduces levels of mutant huntingtin and the risk of neuronal death. Nature. 2004;431(7010):805–810. - PubMed
-
- Bence NF, Sampat RM, Kopito RR. Impairment of the ubiquitin-proteasome system by protein aggregation. Science. 2001;292(5521):1552–1555. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources
